海王生物：2026年第一次临时股东会决议公告

Group 1 - The company, Haiwang Biological, announced the approval of two significant proposals during its first extraordinary shareholders' meeting of 2026 [2] - The first proposal involves the transfer of equity in a controlling subsidiary, which has resulted in passive external financial assistance [2] - The second proposal pertains to the continuation of guarantees that constitute external guarantees [2]